Five year safety and immunogenicity of GlaxoSmithKline's candidate malaria vaccine RTS,S/AS02 following administration to semi-immune adult men living in a malaria-endemic region of The Gambia
Bojang, Kalifa, Milligan, Paul, Pinder, Margaret, Doherty, Tom, Leach, Amanda, Ofori-Anyinam, Opokua, Lievens, Marc, Kester, Kent, Schaecher, Kurt, Ballou, W. Ripley, Cohen, JoeVolume:
5
Language:
english
Journal:
Human Vaccines
DOI:
10.4161/hv.5.4.7050
Date:
April, 2009
File:
PDF, 971 KB
english, 2009